Traditional Chinese medicine prescription with functions of strengthening spleen and nourishing blood and preparation method thereof

Abstract

The invention discloses a traditional Chinese medicine prescription with functions of strengthening the spleen and nourishing blood and a preparation method thereof. The traditional Chinese medicine prescription is prepared from the following components in parts by weight: 25-35g of hairyvein agrimonia herb and bud, 55-65g of milk-vetch roots, 15-25g of white atractylodes rhizomes, 35-45g of glossy privet fruits, 35-45g of yerbadetajo herb, 25-35g of solomonseal rhizomes, 35-45g of lucid ganoderma, 55-65g of peanut coat, 15-25g of folium pyrrosiae, 25-35g of donkey-hide gelatin, 35-45g of unprocessed rehmannia roots, 15-25g of Chinese angelica, 55-65g of white peony roots, 35-45g of suberect spatholobus stems, 15-25g of parched hawthorn fruits, 25-35g of bamboo shavings, 15-25g of processed pinellia tubers and 4-8g of prepared liquorice. Compared with the prior art, the prescription has good effects of strengthening the spleen and replenishing qi, nourishing liver and kidney and enriching and regulating blood, and is capable of enhancing the immunity of human body, helping the human body, alleviating toxic and side effects of chemotherapy drugs, protecting the functions of visceraand bone marrow while chemotherapy is carried out, and ensuring the smooth progress of chemotherapy.

Description

technical field [0001] The invention relates to the field of nutritional compositions, in particular to a traditional Chinese medicine prescription with functions of invigorating spleen and nourishing blood and a preparation method thereof. Background technique [0002] Malignant tumors are diseases that seriously threaten human health and social development. The incidence of malignant tumors in China accounts for about 21.8% of the global incidence of malignant tumors, and some malignant tumors such as gastric cancer, liver cancer, and esophageal cancer account for a relatively high proportion of the global incidence, accounting for 42.6%, 50.5% and 49.0% respectively. Chemotherapy is one of the main treatment methods to kill tumor cells and control tumor growth. However, due to the poor selectivity of current chemotherapy drugs for tumor cells, they also kill normal cells in the human body, especially the actively proliferating bone marrow. Cells, such as granulocytes, le...

AI Technical Summary

Problems solved by technology

Chemotherapy is one of the main treatment methods to kill tumor cells and control tumor growth. However, due to the poor selectivity of current chemotherapy drugs for tumor cells, they also kill normal cells in the human body, especially the actively proliferating bone marrow. Cells, such as granulocytes, lead to bone marrow suppression, mainly manifested as a decrease in white blood cells, red blood cells, and platelets in peripheral blood, which can cause serious adverse reactions such as anemia, infection, and bleeding, which can even endanger the life of the patient.

[0003] The drugs commonly used in the prevention and treatment of myelosuppression in modern medicine are mainly cytokines, which can improve myelosuppression quickly, but the maintenance time is short, and there are adverse reactions such as fever and bone pain; they cannot effectively prevent and treat thrombocytopenia after tumor chemotherapy, and cannot alleviate the side effects of chemotherapy , reducing the completion rate of chemotherapy and radiotherapy

Images